Guided Therapeutics Inc
GTHP· OTC
Filed Nov 13, 2013 · 10-Q · 44 days after period end · 0001121781-13-000411
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $86.00K | $693.00K | $1.02M |
| Net Income | -$1.44M | -$986.00K | -$2.66M |
| EPS Diluted | -$0.02 | -$0.02 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 13, 2013 · 44 d after period end